Febuxostat

CAS No. 144060-53-7

Febuxostat ( FBX; TEI 6720; TMX 67 )

Catalog No. M11869 CAS No. 144060-53-7

Febuxostat is a Xanthine Oxidase Inhibitor. The mechanism of action of febuxostat is as a Xanthine Oxidase Inhibitor.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 29 In Stock
10MG 47 In Stock
25MG 72 In Stock
50MG 96 In Stock
100MG 122 In Stock
200MG 178 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Febuxostat
  • Note
    Research use only, not for human use.
  • Brief Description
    Febuxostat is a Xanthine Oxidase Inhibitor. The mechanism of action of febuxostat is as a Xanthine Oxidase Inhibitor.
  • Description
    Febuxostat is a Xanthine Oxidase Inhibitor. The mechanism of action of febuxostat is as a Xanthine Oxidase Inhibitor.
  • Synonyms
    FBX; TEI 6720; TMX 67
  • Pathway
    Immunology/Inflammation
  • Target
    ROS
  • Recptor
    XO
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    144060-53-7
  • Formula Weight
    316.37
  • Molecular Formula
    C16H16N2O3S
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 63 mg/mL (199.13 mM)
  • SMILES
    O=C(C1=C(C)N=C(C2=CC=C(OCC(C)C)C(C#N)=C2)S1)O
  • Chemical Name
    2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yasuhiro Takano, et al. Life Sciences, 2005 Mar 4; 76(16):1835-47
molnova catalog
related products
  • Riboflavin Tetrabuty...

    Riboflavin Tetrabutyrate is a lipophilic flavin derivative. Riboflavin Tetrabutyrate has antioxidative and lipid peroxide-removing activity.

  • Lycopene

    Extracted from Papaya fruit, marigold flower petals;Store the product in sealed, cool and dry condition.

  • Medicarpin

    Medicarpin a legume phytoalexin acts as an estrogen receptor (ER) agonist can stimulate osteoblast differentiation likely via ERα2 promote achievement of peak bone mass and is devoid of uterine estrogenicity; in addition given its excellent oral bioavailability it can be potential osteogenic agent.